Worth reading
—
Scored from 0 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
700000
sharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Acquisition and cancellation of outstanding stock acquisition rights following the issuance of stock acquisition rights through a third-party allotment
Intended allottee
Macquarie Bank Limited (existing allottee)
Total issue value
Series 2: ¥1,698,000 in total; Series 3: ¥1,828,000 in total
Amount of funds to be raised
No financing was completed through the exercise of the rights; total amount paid in and estimated net proceeds: Not disclosed
Specific use of funds
Research and development of ALiS ZERO®, expansion of the engineering workforce, and development of game titles, among other uses
Terms of the stock acquisition rights
Exercise price
Series 2: ¥3,300; Series 3: ¥4,400. Although the document states that the rights can be converted into stock acquisition rights with an adjustable exercise price, details of the adjustment provisions and the floor price are not disclosed in this document.
Exercise period
From 2 October 2023 to 1 October 2026
Number of Stock Acquisition Rights
Total issued: Series 2: 3,000 rights; Series 3: 4,000 rights. Acquired and cancelled: Series 2: 3,000 rights; Series 3: 4,000 rights. Outstanding after cancellation: 0 rights
Reason for acquisition without consideration
All rights were acquired on the last day of the exercise period at an amount equal to their issue price. Upon expiration of the exercise period, all rights were cancelled in accordance with Article 287 of the Companies Act.
Most recent equity financing
Timing 29 September 2023 / Type Issuance of Series 2 and Series 3 Stock Acquisition Rights of 株式会社ユークス in 2023 / Amount Total issue price: Series 2: ¥1,698,000; Series 3: ¥1,828,000
Impact on Business Performance
The impact of the acquisition and cancellation of these stock acquisition rights on results for the fiscal year is minor.
| Item | Details |
|---|---|
| Type of issuance or disposal | Acquisition and cancellation of outstanding stock acquisition rights following the issuance of stock acquisition rights through a third-party allotment |
| Issue price and disposal price | Series 2: ¥566 per right; Series 3: ¥457 per right (issue price) |
| Total issue value | Series 2: ¥1,698,000 in total; Series 3: ¥1,828,000 in total |
| Amount of funds to be raised | No financing was completed through the exercise of the rights; total amount paid in and estimated net proceeds: Not disclosed |
| Specific use of funds | Details Research and development of ALiS ZERO®, expansion of the engineering workforce, and development of game titles, among other uses / Amount Not disclosed / Scheduled timing of expenditures Not disclosed |
| Intended allottee | Macquarie Bank Limited (existing allottee) |
| Exercise price | Series 2: ¥3,300; Series 3: ¥4,400. Although the document states that the rights can be converted into stock acquisition rights with an adjustable exercise price, details of the adjustment provisions and the floor price are not disclosed in this document. |
| Exercise period | From 2 October 2023 to 1 October 2026 |
| Number of Stock Acquisition Rights | Total issued: Series 2: 3,000 rights; Series 3: 4,000 rights. Acquired and cancelled: Series 2: 3,000 rights; Series 3: 4,000 rights. Outstanding after cancellation: 0 rights |
| Reason for acquisition without consideration | All rights were acquired on the last day of the exercise period at an amount equal to their issue price. Upon expiration of the exercise period, all rights were cancelled in accordance with Article 287 of the Companies Act. |
| Most recent equity financing | Timing 29 September 2023 / Type Issuance of Series 2 and Series 3 Stock Acquisition Rights of 株式会社ユークス in 2023 / Amount Total issue price: Series 2: ¥1,698,000; Series 3: ¥1,828,000 |
| Impact on Business Performance | The impact of the acquisition and cancellation of these stock acquisition rights on results for the fiscal year is minor. |
Items this document does not state (16)
Number of shares to be issued or disposed ofEstimated issuance expensesPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As the discrepancy between the exercise price and the stock price persisted and the rights were not exercised by the exercise deadline, the company acquired all of them on the last day of the exercise period at an amount equal to their issue price, in accordance with the issuance terms.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.